Floatz logo

VITAMIN D

Chronic Lymphoid Leukemia

Semmelweis UniversitymixturePhase 3Dormant
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Chronic Lymphoid Leukemia cohort.

Asset / SponsorPhaseRating
Abt-263
Abbott
Phase 2BB
Anti-Thymoglobulin, Rabbit
University of Liege
Phase 2CCC
Tenofovir Alafenamide
Gruppo Italiano Malattie EMatologiche dell'Adulto
Phase 2CCC
Zanubrutinib
Fred Hutchinson Cancer Center
Phase 2CCC

Same molecule, other indications

VITAMIN D is also rated in:

vitamin D deficiencyDormant
A
Indicative ·
83 / 100
View asset →
osteoporosisDormant
BBB
Indicative ·
76 / 100
View asset →
polycystic ovary syndromeDormant
BBB
Indicative ·
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →